XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
12 Months Ended
Apr. 02, 2022
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
Income tax benefit for Fiscal Years 2022, 2021, and 2020 consisted of the following:
Fiscal Year Ended
(in thousands)April 2, 2022April 3, 2021March 28, 2020
Current   
Federal$(8,703)$(1,895)$15,794 
State465 1,780 2,310 
Foreign9,781 13,740 9,526 
Total current income tax expense1,543 13,625 27,630 
Deferred  
Federal— — (12,899)
State— — (768)
Foreign(121,698)(21,174)(83,364)
Total deferred income tax benefit(121,698)(21,174)(97,031)
Income tax benefit$(120,155)$(7,549)$(69,401)
Schedule of Income before Income Tax, Domestic and Foreign
The components of loss before income taxes for Fiscal Years 2022, 2021, and 2020 are as follows:
Fiscal Year Ended
(in thousands)April 2, 2022April 3, 2021March 28, 2020
United States$(114,124)$(137,433)$(756,095)
Foreign11,886 72,553 (140,488)
Loss before income taxes$(102,238)$(64,880)$(896,583)
Schedule of Effective Income Tax Rate Reconciliation
The following is a reconciliation between statutory federal income taxes and the income tax benefit for Fiscal Years 2022, 2021, and 2020:
Fiscal Year Ended
 (in thousands)April 2, 2022April 3, 2021March 28, 2020
Tax benefit at statutory rate$(21,470)$(13,625)$(188,282)
Foreign operations taxed at different rates(3,376)(11,709)2,497 
State taxes, net of federal benefit(3,164)(5,077)(14,326)
Research and development credit(5,255)(9,725)(6,498)
U.S. tax on foreign earnings196 11,274 10,889 
Reserve expirations(6,570)— — 
Goodwill impairment— — 101,604 
Stock-based compensation6,829 6,751 7,369 
Internal restructuring related benefit(113,426)— (65,069)
Valuation allowance change29,902 23,928 68,486 
Altera accrual— — 9,467 
Tax rate change— (12,418)— 
Nondeductible compensation2,217 1,209 1,187 
Tax on unremitted earnings of certain subsidiaries(3,842)161 (787)
Nondeductible expenses1,216 — — 
Provision to return(3,068)2,707 1,717 
Other, net(344)(1,025)2,345 
Income tax benefit$(120,155)$(7,549)$(69,401)
Schedule of Deferred Tax Assets and Liabilities Significant components of the Company's deferred tax assets and liabilities as of April 2, 2022 and April 3, 2021 are as follows:
(in thousands)April 2, 2022April 3, 2021
Deferred tax assets
Accruals and other reserves$27,431 $36,503 
Deferred compensation4,453 3,717 
Net operating loss carry forward68,920 10,923 
Stock-based compensation5,573 9,939 
Interest expense8,398 23 
Tax credits22,220 13,858 
Capitalized R&D costs56,504 54,725 
Intangible assets164,182 101,362 
Other deferred tax assets7,827 4,610 
Unearned revenue15,583 9,043 
Property, plant, and equipment depreciation3,331 1,045 
Total deferred tax assets, before valuation allowance384,422 245,748 
Valuation allowance(1)
(131,642)(101,740)
Total deferred tax assets, net252,780 144,008 
Deferred tax liabilities
Deferred gains on sales of properties(1,147)(1,137)
Purchased intangibles(27,937)(42,255)
Unremitted earnings of certain subsidiaries(2,070)(889)
Right-of-use assets(6,599)(5,623)
Total deferred tax liabilities(37,753)(49,904)
Net deferred tax assets$215,027 $94,104 
(1) Valuation allowance on federal and state deferred tax assets is net of federal tax impact.
Schedule of Unrecognized Tax Benefits Roll Forward
A reconciliation of the change in the amount of gross unrecognized income tax benefits for the periods is as follows:
Fiscal Year Ended
(in thousands)April 2, 2022April 3, 2021March 28, 2020
Balance at beginning of period$149,466 $152,307 $26,458 
Increase related to prior fiscal years220 8,827 11,226 
Increase related to business combinations— — 89 
Increase related to current year income statement— — 115,824 
Reductions related to settlements with taxing authorities(128,468)(9,668)(995)
Reductions related to lapse of applicable statute of limitations(6,842)(2,000)(295)
Balance at end of period$14,376 $149,466 $152,307